Search
for
Sort by
Research 91–120 of 1000+
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- EGFR Controls Hair Shaft Differentiation in a p53-Independent Manner
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Accelerative action of topical piperonylic acid on mice full thickness wound by modulating inflammation and collagen deposition
- Association between epidermal growth factor and epidermal growth factor receptor gene polymorphisms and susceptibility to alopecia areata in Korean population
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Epidermal growth factor promotes proliferation of dermal papilla cells via Notch signaling pathway
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- mTOR signaling in hair follicle and hair diseases: recent progress
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- Roles of the Hedgehog Signaling Pathway in Epidermal and Hair Follicle Development, Homeostasis, and Cancer
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- DMBA/TPA Treatment Is Necessary for BCC Formation from Patched Deficient Epidermal Cells in Ptch flox/flox CD4Cre +/− Mice
- Expression of Signaling Components in Embryonic Eyelid Epithelium
- Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Management of Toxicities of Targeted Therapies
- Hair follicle stem cell cultures reveal self‐organizing plasticity of stem cells and their progeny
- Gab1 and Mapk Signaling Are Essential in the Hair Cycle and Hair Follicle Stem Cell Quiescence
- RNA sequence analysis of dermal papilla cells’ regeneration in 3D culture
- Scratching the surface of skin development